AddLife AB Bundle
Who Really Owns AddLife AB?
Ever wondered who steers the ship at a leading player in the Life Science sector? Understanding AddLife AB's ownership structure is key to unlocking its strategic vision and potential for growth. From its roots as part of a larger group to its current independent status, the journey of AddLife AB is a fascinating study in corporate evolution.
This deep dive into AddLife AB SWOT Analysis will uncover the key players behind the scenes, from the initial founding ownership to the current
Who Founded AddLife AB?
The story of AddLife AB's ownership begins with its roots in the Addtech Group, specifically within the Life Science business area. This area emerged from the acquisition of parts of the MediTech business from B&B Tools (formerly Bergman & Beving) in 2005. The formal establishment of the AddLife Group occurred in June 2015, solidifying the Life Science segment under its umbrella.
Bergman & Beving, founded in 1906 by Arvid Bergman and Fritz Beving, laid the initial groundwork. They started by importing technical products. The evolution to AddLife involved several strategic shifts, culminating in its independent listing on the stock exchange.
While specific details about early equity splits within the Life Science segment before the spin-off aren't readily available, the IPO in March 2016 marked a significant transition. This event saw AddLife launch a $2 billion IPO on Nasdaq Stockholm, alongside a $300 million share rights issue. The move to an independent listing was a strategic decision to allow the Life Science operations to pursue their own growth.
Founding Origins
AddLife AB's history is tied to the Addtech Group, specifically the Life Science business area. This area was formed after Addtech acquired parts of the MediTech business from B&B Tools in 2005.
Key Figures
Anders Börjesson was noted as the largest owner in terms of votes in AddLife since its spin-off from Addtech. The founders of Bergman & Beving, Arvid Bergman and Fritz Beving, were the initial driving forces.
IPO and Listing
AddLife AB went public on March 16, 2016, with a $2 billion IPO on Nasdaq Stockholm. A $300 million share rights issue was also part of the initial public offering.
Strategic Vision
The independent listing allowed AddLife to focus on its own growth and development. This strategic move was aimed at enhancing the company's potential in the life science sector.
Ownership Structure
The initial ownership structure evolved from the Addtech Group. The IPO and subsequent share issues changed the ownership landscape of AddLife AB, creating opportunities for new AddLife AB investors.
Early Agreements
Details of early agreements, vesting schedules, and buy-sell clauses from the initial phase are not publicly available. The company's early financial performance and growth trajectory are key indicators.
Key Takeaways on AddLife AB Ownership
Understanding the evolution of AddLife AB's ownership provides insight into its strategic journey. From its origins within Addtech to its independent listing, the company's structure has been shaped by key decisions and market dynamics. Here are the key points:
- AddLife AB's ownership structure evolved from its roots in the Addtech Group.
- The IPO in 2016 marked a significant shift in ownership.
- Anders Börjesson was a major shareholder after the spin-off.
- The independent listing was a strategic move to foster growth.
- The initial ownership details are not fully public.
AddLife AB SWOT Analysis
- Complete SWOT Breakdown
- Fully Customizable
- Editable in Excel & Word
- Professional Formatting
- Investor-Ready Format
How Has AddLife AB’s Ownership Changed Over Time?
The ownership structure of AddLife AB has evolved since its initial public offering (IPO) on Nasdaq Stockholm on March 16, 2016. As of December 31, 2024, the company had 11,620 shareholders. The total shares amounted to 122,450,250, consisting of 4,572,796 Class A shares and 117,877,454 Class B shares. Each Class A share holds ten votes, while Class B shares have one vote, although both share classes have equal dividend rights. Only the Class B shares are listed on Nasdaq Stockholm. This structure influences how the company is controlled and how investors participate in its growth. Understanding the shifts in ownership is key to analyzing the AddLife ownership dynamics.
Major stakeholders in AddLife company as of December 31, 2024, included RoosGruppen AB and Tom Hedelius, holding significant voting rights. RoosGruppen AB held 4.7% of the capital and 16.0% of the votes, while Tom Hedelius held 1.7% of the capital and 12.6% of the votes. In September 2017, Roosgruppen AB increased its ownership substantially, becoming the largest owner in terms of votes, holding 24.1% of the total votes. This indicates strategic moves by key players and reflects investor confidence in the company. For more insights, consider the Growth Strategy of AddLife AB.
| Shareholder | Capital (%) | Votes (%) |
|---|---|---|
| RoosGruppen AB | 4.7 | 16.0 |
| Tom Hedelius | 1.7 | 12.6 |
| AMF Fonder AB | 8.78 | N/A |
| SEB Investment Management AB | 8.53 | N/A |
Institutional investors play a vital role in AddLife's ownership structure. As of December 30, 2024, top institutional holders included AMF Fonder AB (8.78%), SEB Investment Management AB (8.53%), ODIN Forvaltning AS (6.92%), Cliens Kapitalförvaltning AB (5.44%), and Forsta AP-fonden (5.01%). Mutual funds and ETFs collectively held 54.44% of outstanding shares as of December 30, 2024. Swedish entities held 51.9% of the capital and votes at year-end 2024, while foreign ownership was 36.4%. The top ten shareholders, by votes, held 51.3% of the votes and 51.7% of the capital as of December 31, 2024. These details are important for anyone interested in AddLife shareholders and AddLife stock.
Key Ownership Facts
Key facts about AddLife's ownership structure and major stakeholders.
- Total shareholders: 11,620 as of December 31, 2024.
- RoosGruppen AB: Major shareholder with significant voting rights.
- Institutional Investors: AMF Fonder AB, SEB Investment Management AB, and others hold substantial shares.
- Mutual Funds/ETFs: Collectively hold over half of the outstanding shares.
- Foreign Ownership: Represents a significant portion of the company's capital.
AddLife AB PESTLE Analysis
- Covers All 6 PESTLE Categories
- No Research Needed – Save Hours of Work
- Built by Experts, Trusted by Consultants
- Instant Download, Ready to Use
- 100% Editable, Fully Customizable
Who Sits on AddLife AB’s Board?
The Board of Directors of AddLife AB plays a key role in the company's governance. According to AddLife's Articles of Association, the board consists of four to six members, elected annually at the Annual General Meeting (AGM). These members serve until the end of the next AGM. The upcoming AGM on May 8, 2025, will see Johan Sjö proposed for re-election as chairman. Kristina Patek is proposed as a new board member, with Håkan Roos, while declining re-election, expressing continued support and intent to remain a significant shareholder. Kristina Patek is considered independent of both AddLife and its executive management, as well as major shareholders. Other directors re-elected in 2023 included Stefan Hedelius, Eva Nilsagård, Birgit Stattin Norinder, and Eva Elmstedt.
The composition of the board and the voting structure are important for understanding AddLife AB's company structure and the interests of its shareholders. The dual-class share system gives significant voting power to Class A shareholders. This structure is a key element in how AddLife ownership is managed and how decisions are made within the company. The board's proposals and the AGM's outcomes shape the company's strategic direction and financial health, impacting AddLife investors.
| Board Member | Proposed Role | Independence |
|---|---|---|
| Johan Sjö | Chairman (re-election) | N/A |
| Kristina Patek | Board Member (proposed) | Independent |
| Håkan Roos | Significant Shareholder | N/A |
AddLife AB's voting structure features a dual-class share system. As of December 31, 2024, the company had 4,572,796 Class A shares and 117,877,454 Class B shares. Each Class A share holds ten votes, while each Class B share holds one vote. This structure gives Class A shareholders greater voting power. Roosgruppen AB and Tom Hedelius are major shareholders due to their Class A shareholdings. For example, RoosGruppen AB held 4.7% of the capital but 16.0% of the votes as of December 31, 2024, and Tom Hedelius held 1.7% of the capital and 12.6% of the votes. The company's commitment to the Swedish Code of Corporate Governance emphasizes transparency. The proposed ordinary dividend for the financial year 2024 is SEK 0.75 per share, to be paid around May 15, 2025.
Key Takeaways on AddLife AB's Governance
The Board of Directors manages AddLife AB, with members elected annually. The upcoming AGM in May 2025 will see key re-elections and new appointments.
- The dual-class share system grants significant voting power to Class A shareholders.
- Major shareholders like Roosgruppen AB and Tom Hedelius hold considerable influence.
- AddLife AB follows the Swedish Code of Corporate Governance, emphasizing transparency.
- A dividend of SEK 0.75 per share is proposed for 2024, payable around May 15, 2025.
AddLife AB Business Model Canvas
- Complete 9-Block Business Model Canvas
- Effortlessly Communicate Your Business Strategy
- Investor-Ready BMC Format
- 100% Editable and Customizable
- Clear and Structured Layout
What Recent Changes Have Shaped AddLife AB’s Ownership Landscape?
Over the past few years, AddLife AB has actively managed its ownership structure through strategic acquisitions and internal share management. A notable acquisition was BonsaiLab, a Spanish distributor, completed on July 4, 2024, expected to contribute approximately SEK 90 million in annual net sales. Furthermore, the acquisition of Edge Medical, finalized on April 1, 2025, and earlier acquisitions like Vision Ophthalmology Group (VOG) and Healthcare 21 (HC21) in 2021, along with MBA in 2022, have expanded its market reach and product offerings. These moves reflect
As of May 8, 2025, AddLife held 586,189 Class B shares in treasury, representing 0.48% of total shares outstanding and 0.36% of the votes. The Annual General Meeting on May 8, 2025, authorized the Board to issue new shares up to 10% to facilitate further acquisitions and bolster its financial position. There have also been conversions of Class A shares to Class B shares, with 42,340 Class A shares converted in 2024, impacting the voting structure. These actions are part of the
Institutional investors significantly influence the
Share Management
AddLife holds shares in treasury. The company's AGM authorized new share issues. Class A shares have been converted to Class B shares.
Institutional Ownership
Institutional investors hold a significant portion of AddLife's shares. Mutual funds and ETFs are major shareholders. Top shareholders control over 50% of votes and capital.
Acquisitions
AddLife has expanded through strategic acquisitions. BonsaiLab was acquired in 2024. Edge Medical was acquired in 2025.
Financials
BonsaiLab acquisition is expected to add SEK 90 million in sales annually. The company focuses on profitability and cash flow. These factors support acquisition-driven growth.
AddLife AB Porter's Five Forces Analysis
- Covers All 5 Competitive Forces in Detail
- Structured for Consultants, Students, and Founders
- 100% Editable in Microsoft Word & Excel
- Instant Digital Download – Use Immediately
- Compatible with Mac & PC – Fully Unlocked
Related Blogs
- What are Mission Vision & Core Values of AddLife AB Company?
- What is Competitive Landscape of AddLife AB Company?
- What is Growth Strategy and Future Prospects of AddLife AB Company?
- How Does AddLife AB Company Work?
- What is Sales and Marketing Strategy of AddLife AB Company?
- What is Brief History of AddLife AB Company?
- What is Customer Demographics and Target Market of AddLife AB Company?
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.